Hudson Bay Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.29M | Sell |
|
|||||
|
2025
Q2 | $5M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.76M | Sell |
|
|||||
|
2024
Q3 | $5.02M | Sell |
|
|||||
|
2024
Q2 | $7.29M | Sell |
|
|||||
|
2024
Q1 | $18.3M | Buy |
|
|||||
|
2023
Q4 | $15.8M | Buy |
|
|||||
|
2023
Q3 | $8.13M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $2.6M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $6.91M | Sell |
|
|||||
|
2019
Q3 | $4.85M | Sell |
|
|||||
|
2019
Q2 | $15.6M | Buy |
|
|||||
|
2019
Q1 | $4.67M | Sell |
|
|||||
|
2018
Q4 | $4.01M | Sell |
|
|||||
|
2018
Q3 | $5.25M | Buy |
|
|||||
|
2018
Q2 | $2.96M | Buy |
|